Skip to main content
Premium Trial:

Request an Annual Quote

Fisher Acquires BioImage in Bid to Grow High-Content Cell-based Assay Play

NEW YORK, April 26 (GenomeWeb News) - Fisher Biosciences has acquired BioImage for an undisclosed amount in an effort to expand its high-content screening and analysis reagent play, the company said today.

 

BioImage plays in the high-content pathway-analysis market. Its Redistribution technology monitors protein translocation within a cell.

 

Fisher said BioImage, based in Copenhagen, Denmark, complements its Cellomics business, which sells automated imaging instruments, BioApplication image-analysis software, high content informatics software, and HitKit HCS reagent kits.

 

Fisher will continue BioImage's operations in Copenhagen.

 

Additional details were not disclosed.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.